Sistemic provide innovative miRNA-based products to the drug development, cell therapy and bioprocessing markets, resulting in enhanced product commercialisation.
Do you develop therapies using Cells & Stem Cells?
We have developed a pioneering product range that aims to provide the standard in cell characterisation and Quality Control (QC). Our SistemQCTM product leverages the instructive power of miRNA based fingerprinting to provide robust, information-rich and cost-effective characterisation and QC methods, applicable to all cells including stem cells.
Are you involved with Drug Discovery & Development?
We have developed key products to expedite drug discovery & development programmes that seamlessly fit within the current workflow processes. Our SistemRNATM product allows companies to get their drugs to market faster by leveraging the instructive power of miRNA based fingerprinting to provide early identification of lead candidate compounds.
The benefits of microRNA (miRNA)
miRNAs are seen as the master controllers of a cell and, as such, We believe they provide information on the effects within a whole cell or organism rather than an isolated pathway. Key benefits of miRNA fingerprinting include cell and tissue specific fingerprinting; stability; reliable biomarker generation; accurate phenotypic description and manageable datasets.
Discover our broad range of products
We have developed a broad range of products from robust quality control (QC) for cells and stem cells, to toxicity and drug response based products for Pharmaceutical markets. These products are helping companies worldwide to deliver drugs and therapies successfully and in a cost-effective manner, whilst providing knowledge-rich and instructive data on a range of cell systems.
Come Meet Us
Edinburgh BioQuarter's SME showcase
Who's Who in Scottish Pharma Outsourcing
10th December 2012,